Basics Verona Pharma Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators. IPO Date: April 24, 2017 Sector: Healthcare Industry: Biotech Market Cap: $9.19B Activated in VL: False Average Daily Range Avg Daily Range: $0.40 | 2.76% Avg Daily Range (30 D): $0.07 | 0.06% Avg Daily Range (90 D): $0.35 | 0.37% Institutional Daily Volume Avg Daily Volume: .45M Avg Daily Volume (30 D): .76M Avg Daily Volume (90 D): 2.54M Trade Size Avg Trade Size (Sh.): 108 Avg Trade Size (Sh.) (30 D): 144 Avg Trade Size (Sh.) (90 D): 176 Institutional Trades Total Inst.Trades: 2,392 Avg Inst. Trade: $3.3M Avg Inst. Trade (30 D): $4.43M Avg Inst. Trade (90 D): $5.71M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $2.97M Avg Closing Trade (30 D): $8.11M Avg Closing Trade (90 D): $6.29M Avg Closing Volume: 52.46K     News Oct 6, 2025 @ 8:05 PM Acquisition of Verona by MSD Approved by the High ... Source: Globe Newswire Sep 24, 2025 @ 8:05 PM Shareholders of Verona Pharma Approve Proposed Acq... Source: Globe Newswire Sep 16, 2025 @ 10:00 AM Verona Pharma to Present Additional Analyses of th... Source: Verona Pharma Sep 3, 2025 @ 5:00 PM PDE4B Inhibitor Market Poised for Strong Growth by... Source: Delveinsight Aug 5, 2025 @ 5:00 PM Global Chronic Obstructive Pulmonary Disease Treat... Source: Delveinsight Financials   TTM Q2 2025 Q1 2025 Basic EPS $.02 $-.02 Diluted EPS $.02 $-.02 Revenue $ $ 103.14M $ 76.26M Gross Profit $ $ $ Net Income / Loss $ $ 11.92M $ -16.32M Operating Income / Loss $ $ 13.31M $ -10.32M Cost of Revenue $ $ $ Net Cash Flow $ $ 36.6M $ 1.66M PE Ratio